The high expression HDAC6 has been suggested to promote the proliferation of lung adenocarcinoma cells [44], and HDAC6 inhibitors have been considered as effective anticancer agents against non-small cell lung cancer [45]. The gene discussed is HDAC6; the disease is non-small cell lung carcinoma.